These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7683028)

  • 21. Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice.
    Desvignes C; Bour H; Nicolas JF; Kaiserlian D
    Eur J Immunol; 1996 Aug; 26(8):1756-61. PubMed ID: 8765017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time course of contact hypersensitivity to DNFB and histologic findings in mice.
    Cho GY; Hough W
    J Korean Med Sci; 1986 Sep; 1(1):31-6. PubMed ID: 3269235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity.
    Schwarz A; Maeda A; Wild MK; Kernebeck K; Gross N; Aragane Y; Beissert S; Vestweber D; Schwarz T
    J Immunol; 2004 Jan; 172(2):1036-43. PubMed ID: 14707077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitizing capacity of Langerhans' cells obtained from ultraviolet-B-exposed murine skin.
    Dai R; Streilein JW
    Immunology; 1995 Dec; 86(4):661-7. PubMed ID: 8567035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic control of contact hypersensitivity. I. I-A subregion as well as non-H-2 loci codes for the gene of 2,4-dinitro-1-fluorobenzene antigen.
    Okuda K; Ishii N; Ikezawa Z; Tani K; Ishigatsubo Y
    Eur J Immunol; 1980 Dec; 10(12):969-71. PubMed ID: 6781912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC/Nga mice in specific-pathogen-free condition.
    Tomimori Y; Tanaka Y; Goto M; Fukuda Y
    J Invest Dermatol; 2005 Jan; 124(1):119-24. PubMed ID: 15654964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen.
    Herrick CA; Xu L; McKenzie AN; Tigelaar RE; Bottomly K
    J Immunol; 2003 Mar; 170(5):2488-95. PubMed ID: 12594274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity.
    Nakae S; Naruse-Nakajima C; Sudo K; Horai R; Asano M; Iwakura Y
    Int Immunol; 2001 Dec; 13(12):1471-8. PubMed ID: 11717188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance.
    Moorhead JW
    J Immunol; 1976 Sep; 117(3):802-6. PubMed ID: 1085311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced contact hypersensitivity by delayed T-helper 2 response in BALB/c mice.
    Hayashi T; Hara S; Hasegawa K
    Allergy Asthma Proc; 2009; 30(4):449-57. PubMed ID: 19772766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity.
    Girolomoni G; Pastore S; Zacchi V; Cavani A; Marconi A; Giannetti A
    J Immunol; 1993 May; 150(10):4236-43. PubMed ID: 8482834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNFB contact sensitivity (CS) in BALB/c and C3H/He mice: requirement for early-occurring, early-acting, antigen-specific, CS-initiating cells with an unusual phenotype (Thy-1+, CD5+, CD3-, CD4-, CD8-, sIg-, B220+, MHC class II-, CD23+, IL-2R-, IL-3R+, Mel-14-, Pgp-1+, J11d+, MAC-1+, LFA-1+, and Fc gamma RII+).
    Ishii N; Takahashi K; Nakajima H; Tanaka S; Askenase PW
    J Invest Dermatol; 1994 Mar; 102(3):321-7. PubMed ID: 7509836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin E production in mice by means of contact sensitization with a simple chemical, hapten.
    Nagai H; Matsuo A; Hiyama H; Inagaki N; Kawada K
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S39-44. PubMed ID: 9440543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of intestinal Bifidobacterium pseudolongum in dietary fructo-oligosaccharide inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity in mice.
    Sasajima N; Ogasawara T; Takemura N; Fujiwara R; Watanabe J; Sonoyama K
    Br J Nutr; 2010 Feb; 103(4):539-48. PubMed ID: 20003567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-1 and PGE2 productions by the regional lymph node cells from DNFB-sensitized mice.
    Natsuaki M; Higasa M; Sagami S; Shinka S
    J Dermatol; 1989 Apr; 16(2):111-5. PubMed ID: 2789244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desensitization of contract allergy to 2,4-dinitro-1-fluorobenzene in mice. II. Characteristics of "immediate" desensitization.
    Mekori YA; Claman HN
    Cell Immunol; 1984 Nov; 89(1):84-94. PubMed ID: 6237740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. IV. Characterization of migration inhibition factor-producing lymphocytes and genetic requirements for activation.
    Moorhead JW; Murphy JW; Harvey RP; Hayes RL; Fetterhoff TJ
    Eur J Immunol; 1982 May; 12(5):431-6. PubMed ID: 7047175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour necrosis factor-alpha mediates ultraviolet light B-enhanced expression of contact hypersensitivity.
    Yoshikawa T; Kurimoto I; Streilein JW
    Immunology; 1992 Jun; 76(2):264-71. PubMed ID: 1634249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between keratinocyte expression of Ia and the intensity and duration of contact hypersensitivity responses in mice.
    Roberts LK; Spangrude GJ; Daynes RA; Krueger GG
    J Immunol; 1985 Nov; 135(5):2929-36. PubMed ID: 3862711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of the contact hypersensitivity reaction by acute morphine administration at the elicitation phase.
    Nelson CJ; How T; Lysle DT
    Clin Immunol; 1999 Nov; 93(2):176-83. PubMed ID: 10527694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.